Mepred 4 Tablet contains Methylprednisolone 4 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory, allergic, and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, asthma, and allergic reactions. Methylprednisolone exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue swelling, redness, and pain. The medication is also utilized in the treatment of certain dermatologic, ophthalmic, and respiratory disorders, as well as in the management of adrenal insufficiency. Mepred 4 Tablet should be administered under medical supervision, with dosage tailored to the severity of the condition and patient response. Caution is advised in patients with infections, diabetes, hypertension, osteoporosis, or peptic ulcer disease, as corticosteroids may exacerbate these conditions. Common side effects include gastrointestinal discomfort, increased susceptibility to infections, mood changes, and fluid retention. Long-term use requires monitoring for potential adverse effects such as adrenal suppression and osteoporosis. Patients should not discontinue therapy abruptly to avoid withdrawal symptoms. Mepred 4 Tablet is a valuable therapeutic agent in controlling inflammation and immune-mediated disorders when used appropriately.